Quality of life in patients with newly diagnosed chronic phase chronic myeloid leukemia on imatinib versus interferon alfa plus low-dose cytarabine: results from the IRIS Study.

Quality of life in patients with newly diagnosed chronic phase chronic myeloid leukemia on imatinib versus interferon alfa plus low-dose cytarabine: results from the IRIS Study. J Clin Oncol. 2003 Jun 01; 21(11):2138-46.

View in: PubMed

subject areas

Adolescent
Adult
Aged
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Benzamides
Cross-Over Studies
Cytarabine
Female
Humans
Imatinib Mesylate
Interferon-alpha
Leukemia, Myeloid, Chronic-Phase
Logistic Models
Male
Middle Aged
Multivariate Analysis
Piperazines
Prospective Studies
Pyrimidines
Quality of Life

authors with profiles

Richard A. Larson